Plural gel

A compound gel and compound technology, applied in the field of compound gel, can solve problems such as aggravating symptoms, achieve the effects of increasing blood flow and velocity, preventing chapping, and promoting tissue repair

Inactive Publication Date: 2016-05-04
杭州惠康医疗器械有限公司
View PDF4 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] Currently common external preparations for preventing and improving skin dryness and chapped skin include alum, calcium salts and magnesium salts and (referring to Patent Publication No. 200

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Plural gel
  • Plural gel
  • Plural gel

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0025] The preparation of embodiment 1 composite gel

[0026] prescription

[0027]

[0028] preparation:

[0029] A bottle: Weigh and weigh 1.8g of 5-aminolevulinic acid compound in the container, and distribute it in a bottle, the specification is 90±5mg;

[0030] Preparation of bottle b: Weigh 21g of poloxamer 407 into a container, add 4.3g of hyaluronic acid, and finally add 74.7g of deionized water, stir well so that all poloxamer 407 is completely dissolved, and let stand . maintain microbiological control operations;

[0031] After all the foam disappears, take a part of it and put it into a 10ml transparent glass bottle, heat it gradually and slowly in a constant temperature water bath, and keep stirring the sample with a thermometer, and record the temperature when the sample in the bottle changes from a liquid state to a gel state. The gel temperature is 23-26°C, and 20 parts are divided into bottle b.

[0032] Mix bottle a and bottle b evenly and let it stan...

Embodiment 2

[0033] The preparation of embodiment 2 composite gel

[0034] prescription

[0035]

[0036] Preparation: bottle a: weigh 3.6g of 5-aminolevulinic acid compound in a container, and distribute it in bottle a, the specification is 180±5mg;

[0037] Preparation of bottle b: Weigh 22.5g of poloxamer 407 into a container, add 5.6g of hyaluronic acid, and finally add 71.9g of deionized water, stir well so that all poloxamer 407 is completely dissolved, and statically place. Maintain microbial control operation; after all the bubbles disappear, take a part of it and put it into a 10ml transparent glass bottle, heat it gradually and slowly in a constant temperature water bath, and keep stirring the sample with a thermometer, record when the sample in the bottle changes from a liquid state to a gel state lower the temperature. The gel temperature is 23-26°C, and 20 parts are divided into bottle b.

[0038] Mix bottle a and bottle b evenly and let it stand for 15 minutes.

Embodiment 3

[0039] The preparation of embodiment 3 composite gel

[0040] prescription

[0041]

[0042] Preparation: bottle a: Weigh and weigh 1.2g of 5-aminolevulinic acid compound in a container, and divide into bottle a, the specification is 60±5mg;

[0043] Preparation of bottle b: Weigh 22g of poloxamer 407 into a container, add 2.8g of hyaluronic acid, and finally add 76.2g of deionized water, stir well so that all poloxamer 407 is completely dissolved, and let stand . maintain microbiological control operations;

[0044] After all the foam disappears, take a part of it and put it into a 10ml transparent glass bottle, heat it gradually and slowly in a constant temperature water bath, and keep stirring the sample with a thermometer, and record the temperature when the sample in the bottle changes from a liquid state to a gel state. The gel temperature is 23-26°C, and 20 parts are divided into bottle b.

[0045] Mix bottle a and bottle b evenly and let it stand for 15 minutes. ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

A plural gel is composed of 5-aminolevulinic acid compound, hyaluronic acid, poloxamer and deionized water and used for assisting in treatment of acne, condyloma acuminata and other hyperproliferative skin diseases by means of a photon therapeutic device. The plural gel has light guiding and heat insulating effects, can prevent scalding, drying, chapping, wrinkling and freckling of skin, and can protect skin and accelerate healing of an affected part.

Description

field of invention [0001] The invention relates to a composite gel, in particular to an external skin gel for assisting the application of photon therapy equipment. Background technique [0002] In recent years, with the improvement of living standards, the busyness and pressure of work and study, the incidence of proliferative skin diseases such as acne and condyloma acuminata is not only high among teenagers, but also among middle-aged people. Therefore, in recent years, the application of photon therapeutic equipment has become more and more extensive. The high-power red light and blue light of specific wavelengths generated by the therapeutic equipment act on the human body, and the photon energy penetrates into the subcutaneous tissue to play a therapeutic role. But at the same time, there are many disadvantages in the direct application of photon therapy equipment to the skin. In the current clinical observation of phototherapy treatment of acne vulgaris, it is found t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K8/86A61K8/73A61K8/44A61K41/00A61Q19/00
CPCA61K8/86A61K8/44A61K8/735A61K41/00A61Q19/00
Inventor 莫关根
Owner 杭州惠康医疗器械有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products